A Thalén

632 total citations
16 papers, 544 citations indexed

About

A Thalén is a scholar working on Genetics, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A Thalén has authored 16 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pharmacology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A Thalén's work include Estrogen and related hormone effects (6 papers), Adrenal Hormones and Disorders (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). A Thalén is often cited by papers focused on Estrogen and related hormone effects (6 papers), Adrenal Hormones and Disorders (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). A Thalén collaborates with scholars based in United Kingdom and United States. A Thalén's co-authors include Ralph Brattsand, Åke Ryrfeldt, Staffan Edsbäcker, Paul Andersson, C. Lindberg, Erik Dahlberg, Ulrika Johansson, Tönu Saartok, Jan-Ακε Gustafsson and Jennifer R. Paulson and has published in prestigious journals such as Molecular Pharmacology, Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition.

In The Last Decade

A Thalén

16 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Thalén United Kingdom 10 172 126 122 99 77 16 544
Amanda Freeman United States 11 113 0.7× 97 0.8× 48 0.4× 72 0.7× 177 2.3× 13 748
Eiji Araki Japan 17 74 0.4× 65 0.5× 18 0.1× 37 0.4× 321 4.2× 41 788
W. F. LIGGETT United States 9 96 0.6× 38 0.3× 19 0.2× 24 0.2× 130 1.7× 14 424
Sang Seop Lee South Korea 20 39 0.2× 41 0.3× 103 0.8× 48 0.5× 237 3.1× 40 859
Carsten Schiller Switzerland 5 71 0.4× 25 0.2× 21 0.2× 28 0.3× 180 2.3× 9 799
Richard V. Flor United States 8 38 0.2× 60 0.5× 32 0.3× 37 0.4× 120 1.6× 12 514
P. Varenne France 11 58 0.3× 26 0.2× 26 0.2× 30 0.3× 187 2.4× 18 573
Jacqueline Chalas France 15 57 0.3× 56 0.4× 25 0.2× 32 0.3× 165 2.1× 39 673
Katsuya Yamasaki Japan 15 64 0.4× 58 0.5× 18 0.1× 67 0.7× 163 2.1× 30 832
Irada Khalilova New Zealand 11 123 0.7× 84 0.7× 22 0.2× 36 0.4× 183 2.4× 14 631

Countries citing papers authored by A Thalén

Since Specialization
Citations

This map shows the geographic impact of A Thalén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Thalén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Thalén more than expected).

Fields of papers citing papers by A Thalén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Thalén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Thalén. The network helps show where A Thalén may publish in the future.

Co-authorship network of co-authors of A Thalén

This figure shows the co-authorship network connecting the top 25 collaborators of A Thalén. A scholar is included among the top collaborators of A Thalén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Thalén. A Thalén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Thalén, A, Ralph Brattsand, & Paul Andersson. (1989). Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.. PubMed. 151. 11–9; discussion 47. 19 indexed citations
2.
Edsbäcker, Staffan, Paul Andersson, C. Lindberg, et al.. (1987). Liver metabolism of budesonide in rat, mouse, and man. Comparative aspects.. Drug Metabolism and Disposition. 15(3). 403–411. 62 indexed citations
3.
Edsbäcker, Staffan, et al.. (1987). Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids.. Drug Metabolism and Disposition. 15(3). 412–417. 14 indexed citations
4.
Andersson, Paul, et al.. (1987). Effect of structural alterations on the biotransformation rate of glucocorticosteroids in rat and human liver. Xenobiotica. 17(1). 35–44. 2 indexed citations
5.
Thalén, A. (1987). Epimers of budesonide and related corticosteroids. III. Synthesis and structure elucidation by carbon-13 and proton nuclear magnetic resonance spectroscopy.. PubMed. 24(3). 97–114. 3 indexed citations
6.
Thalén, A, et al.. (1984). Synthesis and pharmacological properties of some 16 alpha,17 alpha-acetals of 16 alpha-hydroxyhydrocortisone, 16 alpha-hydroxyprednisolone and fluorinated 16 alpha-hydroxyprednisolones.. PubMed. 21(2). 109–24. 4 indexed citations
7.
Dahlberg, Erik, A Thalén, Ralph Brattsand, et al.. (1984). Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.. Molecular Pharmacology. 25(1). 70–78. 116 indexed citations
8.
Edsbäcker, Staffan, Stefán Hrafn Jónsson, C. Lindberg, Åke Ryrfeldt, & A Thalén. (1983). Metabolic pathways of the topical glucocorticoid budesonide in man.. Drug Metabolism and Disposition. 11(6). 590–596. 46 indexed citations
9.
Brattsand, Ralph, et al.. (1982). Development of new glucocorticosteroids with a very high ratio between topical and systemic activities.. PubMed. 122. 62–73. 56 indexed citations
10.
Aherne, G. Wynne, et al.. (1982). A sensitive radioimmunoassay for budesonide in plasma. Journal of Steroid Biochemistry. 17(5). 559–565. 17 indexed citations
11.
Brattsand, Ralph, et al.. (1982). Influence of 16α,17α-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids. Journal of Steroid Biochemistry. 16(6). 779–786. 117 indexed citations
12.
Roth, Gregory P., Anders Wikby, Lars Nilsson, & A Thalén. (1980). High-performance liquid chromatographic determination of epimers, impurities, and content of the glucocorticoid budesonide and preparation of primary standard. Journal of Pharmaceutical Sciences. 69(7). 766–770. 19 indexed citations
13.
Thalén, A & R. Brattsand. (1980). ChemInform Abstract: SYNTHESIS AND ANTIINFLAMMATORY PROPERTIES OF BUDESONIDE, A NEW NON‐HALOGENATED GLUCOCORTICOID WITH HIGH LOCAL ACTIVITY. Chemischer Informationsdienst. 11(10). 2 indexed citations
14.
Thalén, A & Ralph Brattsand. (1979). Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity.. PubMed. 29(11). 1687–90. 55 indexed citations
15.
Claesson, G., et al.. (1963). The Preparation of 3,3,5,5-Tetramethyl-1,2-dithiolane-4-one.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 17. 1172–1173. 7 indexed citations
16.
Claeson, Göran, et al.. (1963). 1,2-Dithiolane and Thietane Derivatives Related to Levulinic Acid.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 17. 2763–2765. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026